Chat with Filing

Ask questions about this document

Please log in or register to use the chat feature. Please register first.

ER - Limes Schlosskliniken AG: Preliminary group result 2023 (unaudited) / forecast 2024

Company: LIMES Schlosskliniken AG Date: 2024-02-06 Language: English Register to download

Loading document preview...

Document Preview Not Available

The file type (.html) cannot be displayed directly here.

Open Original File

Error loading document preview. Please try the 'Open Original File' link.

You're One Click Away From The Full Filing

Instantly access this document—and 2.8M more—for free. Select your preferred method:

Continue with Google Continue with Microsoft Continue with Facebook Continue with Amazon

 News Details

Ad-hoc | 6 February 2024 14:10

#   

Limes Schlosskliniken AG: Preliminary group result 2023 (unaudited) / forecast 2024

Limes Schlosskliniken AG / Key word(s): Annual Results/Forecast  

Limes Schlosskliniken AG: Preliminary group result 2023 (unaudited) / forecast 2024  

  

06-Feb-2024 / 14:10 CET/CEST  

Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group AG.  

The issuer is solely responsible for the content of this announcement.  

  

- - -

**DGAP-Adhoc: Limes Schlosskliniken AG:**

**Preliminary group result 2023 (unaudited) / forecast 2024**

-   **Total revenue EUR 37.4m** **\+ 26 %**  
    
-   **Patient days 46,641** **\+ 26 %**  
    
-   **Gross earnings (EBITDA) 7.4 Mio. EUR** **– 15 %**  
    
-   **Operating result (EBIT) 4.7 Mio. EUR** **– 22 %**  
    
-   **Consolidated net income for the period 3,395 kEUR** **– 30 %**  
    
-   **Earnings after minorities and after taxes (EAT) EUR 3m** **– 30 %**  
    
-   **60% of earnings (EBITDA) were generated in the second half of the year**  
    
-   **Lindlar clinic site: The owner will complete the property by early 2025 and hand it over to LIMES as operator**  
    
-   **Forecast 2024: Strong first half-year expected, double-digit growth at all clinic locations, total revenue EUR 44 m + 18 %; Commissioning of the new clinic location Abtsee in Q III; gross earnings (EBITDA) EUR 9.7 m (+ 31 %) incl. Start-up costs Abtsee**

Cologne, February, 06, 2024:  The LIMES Group continued to develop dynamically in 2023. The new location in Liechtenstein has been integrated and is performing significantly better than planned. Patient occupancy was higher at all locations in the second half of the year.  After higher costs had to be covered in the first half of 2023 due to inflation, these were largely compensated by delayed price adjustments in the second half of the year.

For the current year 2024, we expect sales revenue of around EUR 44 million excluding new acquisitions and gross earnings (EBITDA) of EUR 9.7 million including the start-up losses of the new Abtsee site near Salzburg.

Kurzprofil: Die LIMES Schlosskliniken Gruppe betreibt hochwertige Privatkliniken für Stressfolgeerkrankung, Mentale und Seelische Störung, wie z. B. Despressionen, Affektive Störungen und akute Burnout Zustände. Das Angebot richtet sich an Privatpatienten, Beihilfeberechtigte und Selbstzahler. Die LIMES Schlosskliniken Gruppe stehen für den besonderen Ansatz einer beziehungsorientierten Medizin in der Behandlung von Menschen mit seelischen Erkrankungen. Dabei wird den Patienten, neben medizinischer Spitzenqualität, eine einzigartige, geschützte und heilsame Umgebung geboten, in der sie ganzheitlich genesen können. Weitere Informationen sind unter [www.limes-schlosskliniken.de](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=2ea2e71167c8b5caaa6e71e3ebac47c0&application_id=1831535&site_id=news_data&application_name=news) abrufbar.

Ihr Ansprechpartner bei Rückfragen:  

LIMES Schlosskliniken AG, Petra Kaes, Investor Relations  

Kaiser-Wilhelm-Ring 26, 50672 Köln  

Tel.: 0221 669 615 10, [p.kaes@limes.care](mailto:p.kaes@limes.care) , [www.limes-schlosskliniken.de](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=2ea2e71167c8b5caaa6e71e3ebac47c0&application_id=1831535&site_id=news_data&application_name=news)  

  

Sprache:   Deutsch  

Unternehmen: LIMES Schlosskliniken AG, Kaiser-Wilhelm-Ring 26, 50672 Köln, Deutschland  

Telefon:      49 221 669 615 10  

Email: [p.kaes@limes.care](mailto:p.kaes@limes.care)  

Internet: [www.limes-schlosskliniken.de](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=redirect&url=2ea2e71167c8b5caaa6e71e3ebac47c0&application_id=1831535&site_id=news_data&application_name=news)  

ISIN:  DE000A0JDBC7  

WKN:  AOJDBC  

Börsen:  Düsseldorf Freiverkehr, Primärmarkt, XETRA  

  

Ende der Mitteilung

  

  

End of Inside Information  

- - -

06-Feb-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.  

Archive at www.eqs-news.com  

- - -

|     |     |
| --- | --- |
| Language: | English |
| Company: | Limes Schlosskliniken AG |
|     | Kaiser-Wilhelm-Ring 26 |
|     | 50672 Köln |
|     | Germany |
| ISIN: | DE000A0JDBC7 |
| WKN: | A0JDBC |
| Listed: | Regulated Unofficial Market in Dusseldorf |
| EQS News ID: | 1831535 |

  

|     |     |
| --- | --- |
|     |     |
| End of Announcement | EQS News Service |

![show this](https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1831535&application_name=news&site_id=news_data)

Unlock Europe's Largest Financial Database—Free

Get instant access to over 2.8M filings from 8,970 companies across 44 markets. No cost. No hassle. Just results.